Business · 14/01/1994Updated: 10/15/2026 · 1 min read
Prospective Grant of Exclusive License: Cell Stress Transcriptional Factors
Summary
The National Institutes of Health (NIH) is contemplating the grant of an exclusive world-wide license to StressTech Biomedical, Inc. for the invention embodied in U.S. Patent Application SN 07/617,910, entitled 'Cell Stress Transcriptional Factors'. The license will be royalty-bearing and limited to commercial screening assay services and kits.
Original source language: Federal Register — Health and Human ServicesOpen original release →